iSpecimen appoints Robert Lim as CEO and director effective Dec. 9, 2024

iSpecimen Inc.

Robert Lim appointed CEO and board member; will provide strategic leadership and advisory services.
Annual fee of $270,000 payable to Lim's personal corporation, 1513932 B.C. Ltd., in monthly installments.
Lim is principal and co-founder of De Novo Law Corporation; brings legal, marketing, and business experience.
No familial relationships with other directors/officers; no reportable legal proceedings in past 10 years.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.